Cesium carbonate → ethyl ((1S)-5-{3-[2-propoxy-4-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)phenoxy]propoxy}-2,3-dihydro-1h-inden-1-yl)acetate

HRID 2235900ノート

反応式

HRID 2235900 の反応式
[OH:1][C:2]1[CH:27]=[C:26]([C:28]2[S:29][C:30]3[CH2:36][CH2:35][CH2:34][CH2:33][C:31]=3[N:32]=2)[CH:25]=[CH:24][C:3]=1[O:4][CH2:5][CH2:6][CH2:7][O:8][C:9]1[CH:10]=[C:11]2[C:15](=[CH:16][CH:17]=1)[C@H:14]([CH2:18][C:19]([O:21][CH2:22][CH3:23])=[O:20])[CH2:13][CH2:12]2.C([O-])([O-])=O.[Cs+].[Cs+].I[CH2:44][CH2:45][CH3:46]>CN(C=O)C.O>[CH2:44]([O:1][C:2]1[CH:27]=[C:26]([C:28]2[S:29][C:30]3[CH2:36][CH2:35][CH2:34][CH2:33][C:31]=3[N:32]=2)[CH:25]=[CH:24][C:3]=1[O:4][CH2:5][CH2:6][CH2:7][O:8][C:9]1[CH:10]=[C:11]2[C:15](=[CH:16][CH:17]=1)[C@H:14]([CH2:18][C:19]([O:21][CH2:22][CH3:23])=[O:20])[CH2:13][CH2:12]2)[CH2:45][CH3:46]

参加物

6

実験手順

Ethyl ((1S)-5-{3-[2-hydroxy-4-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-phenoxy]-propoxy}-2,3-dihydro-1H-inden-1-yl)acetate (Example 165, 90 mg, 0.177 mmol) was dissolved in DMF (3 mL) after which Cs2CO3 (69.3 mg, 0.213 mmol) and water (3 drops) were added. Iodopropane (0.02 mL, 0.213 mmol) was added to the flask, and the reaction mixture was stirred at room temperature for 18 h. The mixture was then filtered and the filtrate purified by preparative HPLC giving the desired ester as a white solid (88.7 mg, 91%). 1H NMR (400 MHz, CD2Cl2): δ 7.47 (s, 1H), 7.37 (dd, 1H), 7.05 (d, 1H), 6.93 (d, 1H), 6.79 (s, 1H), 6.71 (dd, 1H), 4.23 (t, 2H), 4.19-4.13 (m, 4H), 4.03 (t, 2H), 3.50 (m, 1H), 2.94-2.78 (m, 6H), 2.70 (dd, 1H), 2.44-2.25 (m, 4H), 1.92-1.70 (m, 7H), 1.28 (t, 3H), 1.07 (t, 3H).

後処理

  1. additionwere added
  2. filtrationThe mixture was then filtered
  3. customthe filtrate purified by preparative HPLC

出典と根拠

ORDレコード
ord-c7200d6ade6f4ce6a9c4709c7d5cfda5
出典データセット
uspto-grants-2010_05
特許番号
US07714004B2

反応ノート

読み込み中…